{"id":"W3204077794","doi":"10.1016/j.annonc.2021.08.326","title":"47P Derazantinib for patients with intrahepatic cholangiocarcinoma harboring FGFR2 fusions/rearrangements: Primary results from the phase II study FIDES-01","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Baker Hughes (Canada)","funders":"Astellas Pharma; Eisai; Merck; Exelixis; Genentech; AstraZeneca; Pfizer","keywords":"Medicine; Fides; Intrahepatic Cholangiocarcinoma; Gastroenterology; Internal medicine; Cancer research; Oncology; Theology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008054805,0.0007638533,0.001403522,0.0002658508,0.0002625343,0.0009431245,0.0003144736,0.0005108239,0.001996747],"category_scores_gemma":[0.0004487526,0.0002985405,0.001209949,0.0003669658,0.0003844632,0.0006145744,0.0002619502,0.001421827,0.0006690577],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009300219,"about_ca_system_score_gemma":0.0008742494,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001281669,"about_ca_topic_score_gemma":0.005849972,"domain_scores_codex":[0.9997585,0.00008613673,0.00001425522,0.00003928447,0.00003149541,0.00007024103],"domain_scores_gemma":[0.9997664,0.00004507812,0.00004723372,0.00002386959,0.00001835763,0.00009912645],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3400481,0.01158489,0.04433192,0.001623547,0.004615117,0.0009256699,0.0003267751,0.008532116,0.09440897,0.0008238599,0.01702213,0.4757569],"study_design_scores_gemma":[0.4062916,0.2833151,0.2095548,0.0003735475,0.007357811,0.005120169,0.0006254622,0.008227065,0.03270049,0.001537528,0.04467402,0.0002225075],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9868658,0.00563971,0.0004237619,0.0009216104,0.0001147048,0.0003118991,0.002125853,0.0000851712,0.00351156],"genre_scores_gemma":[0.987743,0.003920443,0.0007107399,0.000662817,0.00007813786,0.0002693925,0.004599399,0.00003680616,0.001979244],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001996747,"threshold_uncertainty_score":0.006747842,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05819853437000666,"score_gpt":0.36047097577529,"score_spread":0.3022724414052834,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}